ICD-10 Specific code E89.3: Postprocedural hypopituitarism
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Postprocedural hypopituitarism |
French
|
Hypopituitarisme après un acte à visée diagnostique et thérapeutique |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | IV | Endocrine, nutritional and metabolic diseases | |
| 2 | E70-E90 | Metabolic disorders | |
| 3 | E89 | Postprocedural endocrine and metabolic disorders, not elsewhere classified | |
| 4 | E89.3 | Postprocedural hypopituitarism |
Indicated medicines
| Active Ingredient |
|---|
|
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |